Page 3 - Nasdaq Hrow News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq hrow. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Hrow Today - Breaking & Trending Today

Harrow Health (NASDAQ:HROW) Shares Gap Up on Insider Buying Activity

Harrow Health, Inc. (NASDAQ:HROW – Get Free Report)’s stock price gapped up before the market opened on Tuesday following insider buying activity. The stock had previously closed at $17.28, but opened at $17.64. Harrow Health shares last traded at $17.73, with a volume of 81,425 shares trading hands. Specifically, CEO Mark L. Baum acquired 5,800 […] ....

Markl Baum , Martina Makary , News Ratings For Harrow Health Daily , Clarivest Asset Management , B Riley Financial Inc , Silver Oak Securities Incorporated , Harrow Health , Securities Exchange Commission , Eton Pharmaceuticals Inc , Harrow Health Price Performance , Institutional Investors Weigh In On Harrow Health , Pharmaceuticals Inc , Surface Ophthalmics Inc , Mendota Financial Group , Harrow Health Inc , Get Free Report , Director Martin , Exchange Commission , Street Capital , Oak Securities Incorporated , Financial Group , Vest Asset Management , Surface Ophthalmics , Melt Pharmaceuticals , Eton Pharmaceuticals , Harrow Health Daily ,

Harrow Health (NASDAQ:HROW) Given New $34.40 Price Target at LADENBURG THALM/SH SH

Harrow Health (NASDAQ:HROW – Free Report) had its price objective upped by LADENBURG THALM/SH SH from $33.70 to $34.40 in a report published on Thursday morning, FlyOnTheWall reports. HROW has been the subject of a number of other research reports. B. Riley upped their price target on Harrow Health from $42.00 to $45.00 and gave […] ....

Blackrock Inc , Surface Ophthalmics Inc , Harrow Health , News Ratings For Harrow Health Daily , Harrow Health Stock Performance , Harrow Health Inc , Eton Pharmaceuticals Inc , Wasatch Advisors Inc , Pharmaceuticals Inc , Prelude Capital Management , Hedge Funds Weigh In On Harrow Health , Envestnet Asset Management Inc , Free Report , Street Capital , Get Free Report , Asset Management , Capital Management , State Street Corp , Street Corp , Surface Ophthalmics , Melt Pharmaceuticals , Eton Pharmaceuticals , Harrow Health Daily , Nasdaq Hrow , Boost Price Target , Ladenburg Thalm Sh ,

Harrow Health (NASDAQ:HROW) Issues Quarterly Earnings Results, Misses Estimates By $0.01 EPS

Harrow Health (NASDAQ:HROW – Get Free Report) issued its quarterly earnings data on Wednesday. The company reported ($0.02) earnings per share for the quarter, missing the consensus estimate of ($0.01) by ($0.01), Briefing.com reports. Harrow Health had a negative return on equity of 1.57% and a negative net margin of 19.76%. The firm had revenue […] ....

Earnings History For Harrow Health , Eton Pharmaceuticals Inc , Harrow Health Trading Down , Tower Research Capital , Surface Ophthalmics Inc , Northwestern Mutual Wealth Management Co , Harrow Health Inc , Institutional Investors Weigh In On Harrow Health , Pharmaceuticals Inc , News Ratings For Harrow Health Daily , Harrow Health , Get Free Report , Health Trading Down , Mutual Wealth Management , Research Capital , Forest Capital Management , Captrust Financial Advisors , Lake Street Capital , Surface Ophthalmics , Melt Pharmaceuticals , Eton Pharmaceuticals , Harrow Health Daily , Nasdaq Hrow ,

Q2 2023 Earnings Estimate for Harrow Health, Inc. Issued By B. Riley (NASDAQ:HROW)

Harrow Health, Inc. (NASDAQ:HROW – Free Report) – Investment analysts at B. Riley lifted their Q2 2023 earnings estimates for shares of Harrow Health in a note issued to investors on Thursday, July 20th. B. Riley analyst M. Mamtani now forecasts that the company will earn $0.00 per share for the quarter, up from their […] ....

Eton Pharmaceuticals Inc , Harrow Health Price Performance , Pharmaceuticals Inc , Harrow Health Company Profile , Surface Ophthalmics Inc , News Ratings For Harrow Health Daily , Fred Alger Management , Squarepoint Ops , Steward Partners Investment Advisory , Harrow Health Inc , Harrow Health , Free Report , Get Free Report , Lake Street Capital , Street Corp , Partners Investment Advisory , Surface Ophthalmics , Melt Pharmaceuticals , Eton Pharmaceuticals , Harrow Health Daily , Nasdaq Hrow , Earnings Estimates , B Riley ,

Harrow Health, Inc. (NASDAQ:HROW) Short Interest Update

Harrow Health, Inc. (NASDAQ:HROW – Get Free Report) was the recipient of a significant growth in short interest in June. As of June 30th, there was short interest totalling 3,850,000 shares, a growth of 33.2% from the June 15th total of 2,890,000 shares. Based on an average daily trading volume, of 521,100 shares, the days-to-cover […] ....

Zurcher Kantonalbank Zurich Cantonalbank , Marshall Wace , Surface Ophthalmics Inc , Harrow Health , Harrow Health Inc , Jump Financial , Pharmaceuticals Inc , Mendota Financial Group , Harrow Health Price Performance , Harrow Health Company Profile , Eton Pharmaceuticals Inc , News Ratings For Harrow Health Daily , Get Free Report , Financial Group , Lake Street Capital , Surface Ophthalmics , Melt Pharmaceuticals , Eton Pharmaceuticals , Harrow Health Daily , Nasdaq Hrow ,